Categories: Wire Stories

Juniper Research: Buy Now Pay Later Spend to Accelerate, Reaching Over $437 Billion Globally by 2027; Fuelled by Deteriorating Macro-economic Factors

BASINGSTOKE, England–(BUSINESS WIRE)–#bnplmarket–A new study from Juniper Research has found consumer spending using BNPL (Buy Now, Pay Later) platforms will reach $437 billion globally in 2027; rising from $112 billion in 2022. This sizeable growth of 291% will be driven by escalating financial pressures from the rising cost of living, increasing demand for cheap credit solutions.

BNPL schemes allow consumers to pay using regular interest-free instalments, which is attractive to those reliant on credit for purchases. Additionally, BNPL only requires soft credit checks; making it easier to access than credit.

The Debt Trap Necessitates Regulation

The research found the most significant issue currently facing the BNPL market is the debt trap. BNPL�s lack of credit checks poses a considerable market hurdle, as consumers are being approved for larger loans than they are actually able to repay. However, the report predicts the introduction of financial regulations in several countries will help alleviate this issue. These new regulations are similar to existing credit services. In markets where regulations are softer, it is still vital that vendors act responsibly and clearly communicate all incurred debts promptly to users; helping minimise repayment default rates.

Research author Dominique Tetnowski explained: “Though the future of the market seems unclear given the plethora of impending regulatory changes, enforcing legislation for eligibility checks will ensure the market develops securely.”

Expansion into New Verticals Needed

The research predicts BNPL vendors must look to provide services in alternative verticals to diversify their monetisation opportunities, as eCommerce becomes oversaturated with solutions. It identified the healthcare sector as an emerging opportunity for vendors, owing to a lower risk of defaulting payments from overspending in comparison to the eCommerce market. As such, vendors must look to make strategic partnerships with established healthcare providers to offer BNPL services to healthcare users; ensuring successful entry into the market.

View the BNPL market research: https://www.juniperresearch.com/researchstore/fintech-payments/buy-now-pay-later-research-report

Download the whitepaper: https://www.juniperresearch.com/whitepapers/bnpl-reshaping-the-payments-landscape

Juniper Research provides research and analytical services to the global hi-tech communications sector; providing consultancy, analyst reports, and industry commentary.

Contacts

Contact Sam Smith, Press Relations

T: +44(0)1256 830002

E: sam.smith@juniperresearch.com

Alex

Recent Posts

Fabrinet Announces Third Quarter Fiscal Year 2024 Financial Results

Exceeds Guidance Ranges with Record Revenue and Net Income Per Share BANGKOK--(BUSINESS WIRE)--Fabrinet (NYSE: FN),…

5 hours ago

South Korea Data Center Market Investment Analysis Report 2024-2029: Opportunities in IT, Electrical, Mechanical Infrastructure, General Construction, and Tier Standards – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "South Korea Data Center Market - Investment Analysis & Growth Opportunities 2024-2029" report…

8 hours ago

Revitalized “Marco Polo” Opera Celebrates Sino-Italian Ties at Guangzhou Opera House

GUANGZHOU, China--(BUSINESS WIRE)--On May 3rd and 4th, the Guangzhou Opera House welcomed nearly 200 international…

9 hours ago

BrainChip Earns Australian Patent for Improved Spiking Neural Network

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world’s first…

9 hours ago

NetApp Appoints Market Growth and Revenue Operations Leader, Dallas Olson to Chief Commercial Officer Role

SAN JOSE, Calif.--(BUSINESS WIRE)--NetApp (NASDAQ: NTAP), the intelligent data infrastructure company, today announced Dallas Olson…

10 hours ago

Biocytogen Enters Into Evaluation and Potential Licensing Agreement With BioCopy For TCR-mimic Antibodies

BEIJING--(BUSINESS WIRE)--#Antibody--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotechnology company focused on…

11 hours ago